Shangbay Capital
Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Shangbay Capital Information
Geographic Data
Address: 530 Lytton Ave.
City: Palo Alto
State: CA
Zip: 94301
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$35M
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
ShangBay Capital is a venture capital firm that invests in medical device technology, biotechnology and mobile healthcare sectors.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2023 | Alleviant Medical | Venture Round | 0 |
| 9/2020 | Aqua Medical | Series A | 0 |
| 5/2018 | NeuroVasc Technologies, Inc | Series B | 6.3M |
| 1/2023 | Telesair | Series A | 22M |
| 11/2022 | Luminopia | Seed Round | 0 |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 1/2016 | Refuge Biotechnologies | Series A | 8.9M |
| 4/2018 | Emboline | Series B | 10M |
| 7/2021 | IgGenix | Series A | 0 |
| 10/2018 | Berkeley Lights | Series E | 0 |
| 9/2021 | Laplace Interventional | Series A | 0 |
| 5/2019 | Apostle | Series A | 3.3M |
| 8/2021 | Fluid Biomed Inc. | Seed Round | 0 |
| 1/2021 | SetPoint Medical | Venture Round | 0 |
| 2/2022 | Huma.AI | Series A | 0 |
| 5/2018 | Refuge Biotechnologies | Series B | 0 |
| 5/2021 | Emboline | Series D | 0 |
| 1/2023 | SetPoint Medical | Venture Round | 0 |
| 11/2022 | Contraline | Series A | 0 |
| 2/2018 | Zenflow | Series A | 31.4M |
| 6/2023 | Presidio Medical | Series C | 0 |
| 10/2021 | Contraline | Series A | 0 |
| 3/2023 | Flare Therapeutics | Series B | 0 |
| 10/2019 | Meditrina, Inc | Venture Round | 13M |
| 5/2017 | Ceribell | Series A | 13M |
| 3/2020 | Zeto | Series A | 7.3M |
| 6/2019 | Corinth MedTech | Series D | 12M |
| 1/2020 | Zap Surgical Systems | Private Equity Round | 0 |
| 8/2019 | Lucira Health | Series B | 15M |
| 7/2020 | OrthoFX | Series A | 13M |
| 7/2021 | Neuro42 | Series A | 6.5M |
| 5/2019 | Atia Vision | Series D | 0 |
| 2/2022 | Huma.AI | Series A | 0 |
| 10/2021 | Contraline | Series A | 0 |
| 9/2021 | Laplace Interventional | Series A | 0 |
| 8/2021 | Fluid Biomed Inc. | Seed Round | 0 |
| 7/2021 | IgGenix | Series A | 0 |
| 7/2021 | Neuro42 | Series A | 0 |
| 5/2021 | Emboline | Series D | 0 |
| 3/2021 | EpimAb Biotherapeutics | Series C | 0 |
| 1/2021 | SetPoint Medical | Venture Round | 0 |
| 9/2020 | Aqua Medical | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
